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It has been an excellent year for the International Association for the Study of LungCancer and the Journal of Thoracic Oncology. There were a record number of abstracts
and attendees at the 14th World Congress in Amsterdam. Similarly, the journal received
a record number of 1200 electronic submissions in 2011. This has necessitated a decrease
in the acceptance rate to 20% and resulted in increasing quality of the published articles.
The average time to first decision for original articles is 25 days, but our challenge remains
to reduce the time to first decision for those 10 to 15% that take the longest.
Journal of Thoracic Oncology is fortunate to have a superb group of Associate
Editors who do an outstanding job of managing manuscripts and selecting reviewers with
appropriate expertise. We are thankful for our reviewers for their selfless contributions to
the peer review process. Without these contributions, the journal would fail to exist. We
will publish the names of the reviewers for 2011 in the March edition of 2012 as we did
last year.
The countries of origin of the submitted manuscript are representative of our
international organization with 40% from Asia/Australia, 30% from Europe, and 25%
from North America. The journal received only three submissions from South America,
three from the Middle East, two from Africa, and none from Russia. Clearly, these are
areas of the world on which the International Association for the Study of Lung Cancer
and Journal of Thoracic Oncology need to focus our lung cancer information and
educational message. South America has demonstrated increasing efforts to advance
clinical and research activity in thoracic oncology as evidenced by the Latin America
Conferences on Lung Cancer including the planned 5th Latin American Conference that
will be held in Rio de Janeiro, Brazil, in July 2012.
In 2011, we saw the first Journal of Thoracic Oncology publications of the Chinese
and French editions. This has been largely due to the efforts of Drs. Yi-Long Wu and Tony
Mok, editors, of the Chinese edition and Dr. Jean-Louis Pujol, editor, of the French
edition. Editors pick selected articles from the English edition of Journal of Thoracic
Oncology for translation into their respective journals. These translations are of enormous
benefit in reaching physicians and scientists who are not fluent or confident in their ability
to read and understand English. Journal of Thoracic Oncology editorial board extends our
congratulations and sincere thanks to Drs. Mok, Wu, and Pujol.
I wish to bring your attention to the fact that we are able to publish video clips as
supplemental digital content. Articles with supplemental digital content are now indicated
by SDC printed next to the page number in the table of contents. In 2011, we published
only two video clips.1,2 We are definitely interested in increasing these numbers in 2012.
Accordingly, I would encourage you to submit interesting and educational video clips with
your manuscripts when you think they are appropriate. For any images that include
patients, be sure to obtain the patients’ permission to publish the video clip. Most video
clips should be no more than 60 seconds, but exceptions will be considered on a case by
case basis.
Journal of Thoracic Oncology Web site contains an area that is called “Quick
Poll” and the question changes every 4 to 6 weeks. In general, we have received
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between 100 and 200 responders with each question. To
date, we have not been able to provide the correct answer
to the questions asked. Often there is no correct answer as
it is just an opinion. However, now we will be able to give
you immediate feedback. In September/October, we posted
the following question, “Recently a lung cancer prediction
model was developed based on the prostate, lung, colon,
ovarian (PLCO) screening trial. Which of the following
was not an important predictor of risk for lung cancer”
(Ref: Tammemagi, et al. J Natl Cancer Inst 103: 1058–
1068, 2011). Twenty-two percent answered correctly that
sex was not an important independent predictive factor of
risk. Fifty percent answered incorrectly that body mass
index was not a predictor. In fact, low body mass (under-
weight) was a predictor of increased risk of lung cancer
(see above reference). In the future, we will provide the
answer to the “Quick Poll” to you immediately if there is
a correct answer.
On behalf of the Journal of Thoracic Oncology staff
and editorial board, thank you for your tremendous support as
an author, reviewer, or reader of the journal. I appreciate your
support and would welcome your comments and/or sugges-
tions to help improve our/your journal.
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